Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,104 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

NCT02797964

Conditions
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL), Anemia, Anemia, Aplastic, +38 more
Locations
  • Royal Marsden Hospital Sutton, London, United Kingdom
  • Belfast City Hospital Belfast, Northern Ireland, United Kingdom
  • Oxford University Hospitals Headington, Oxford, United Kingdom
  • Velindre Cancer Centre - Cardiff Cardiff, Whitchurch, United Kingdom
View all 15 locations
View Trial Details
Completed

A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene

NCT02141828

Conditions
Acute Leukemias, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +13 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Emory Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Completed

Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia

NCT00003764

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
View all 218 locations
View Trial Details
Completed

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

NCT01618136

Conditions
Adnexal Diseases, Advanced Melanoma, B-cell Malignancy, Low-grade, +37 more
Locations
  • King's College London Guy's Hospital Campus London, United Kingdom
  • Newcastle Upon Tyne NHS Foundation Trust Newcastle Upon Tyne and Wear, United Kingdom
View Trial Details
Completed

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

NCT00217425

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • California Cancer Care, Incorporated - Greenbrae Greenbrae, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
View all 110 locations
View Trial Details

Related conditions